Neuland Lab Share Price
Neuland Lab Share Price Today
As of 25 Jul 2026, Neuland Lab share price is ₹18,525.00. The stock opened at ₹18,250.00, compared to its previous close of ₹18,431.00. During today's trading session, Neuland Lab share price moved in the range of ₹18,234.00 to ₹18,664.00, with an average price of ₹18,449.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹11,500.00 and a high of ₹20,089.00. On the performance front, Neuland Lab share price has increased by 39.96% over the last six months and is up 34.38% on a year-on-year basis.
Neuland Lab Returns Calculator
Neuland Lab Shareholder Returns
Neuland Lab Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,68,842.00 | 36.73 | 5.05 | 14.85% | 0.55 | 18.72% | 18.85 | 0.91% | 0.56 | 10.90 |
| Divis Laboratories | 1,93,860.00 | 61.36 | 9.40 | 16.19% | 0.00 | 21.00% | 9.43 | 0.50% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,92,687.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,12,593.00 | 33.55 | 3.27 | 11.27% | 0.00 | 14.95% | 423.36 | 0.93% | 0.44 | 43.52 |
| Zydus Lifesciences | 1,11,082.00 | 17.39 | 3.23 | 19.69% | 0.35 | 20.30% | 3.70 | 0.11% | 0.39 | 35.38 |
| Lupin | 1,09,553.00 | 19.83 | 4.71 | 27.01% | 0.03 | 27.44% | 3.51 | 0.78% | 0.61 | 129.18 |
| Mankind Pharma | 1,05,607.00 | 1.05 | 0.12 | 12.65% | 0.42 | 12.97% | 5.05 | 0.05% | 0.54 | 49.37 |
| Dr. Reddy's Laboratories | 97,364.90 | 30.58 | 2.56 | 11.07% | 0.18 | 12.54% | 377.96 | 0.69% | 0.41 | 38.68 |
| Aurobindo Pharma | 88,508.40 | 25.27 | 2.34 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 84,727.30 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Neuland Lab Financials
Income Statement · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹2,022.99 | ₹1,476.84 | ₹1,558.58 | ₹1,191.20 |
| Other Income | ₹30.17 | ₹20.51 | ₹12.54 | ₹9.75 |
| Total Revenue | ₹2,053.15 | ₹1,497.35 | ₹1,571.12 | ₹1,200.95 |
| Total Expenses | ₹1,564.17 | ₹1,227.42 | ₹1,169.69 | ₹985.20 |
| Profit Before Tax | ₹488.98 | ₹346.33 | ₹401.44 | ₹215.75 |
| Tax | ₹124.98 | ₹86.22 | ₹101.36 | ₹52.23 |
| Profit After Tax | ₹364.00 | ₹260.11 | ₹300.08 | ₹163.52 |
| EPS - Basic | ₹283.71 | ₹202.74 | ₹233.89 | ₹127.45 |
| EPS - Diluted | ₹283.71 | ₹202.74 | ₹233.89 | ₹127.45 |
Cash Flow · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹488.98 | ₹346.33 | ₹401.44 | ₹215.75 |
| Income before WC changes | ₹591.63 | ₹334.35 | ₹463.51 | ₹293.67 |
| Change in Assets | -₹359.46 | ₹28.58 | -₹99.00 | -₹153.28 |
| Change in Liabilities | ₹218.04 | ₹29.21 | ₹8.27 | ₹140.45 |
| Change in WC | -₹141.42 | ₹57.78 | -₹90.73 | -₹12.83 |
| Cash flow from Operations | ₹346.68 | ₹317.40 | ₹261.18 | ₹237.21 |
| Cash flow from Investing | -₹423.73 | -₹298.16 | -₹149.69 | -₹61.50 |
| Cash flow from Financing | ₹20.98 | ₹24.96 | -₹69.28 | -₹135.80 |
| Total Cash Flow | -₹56.08 | ₹44.21 | ₹42.21 | ₹39.92 |
| Cash (Start of the year) | ₹131.93 | ₹87.58 | ₹45.42 | ₹5.09 |
| Cash (End of the year) | ₹76.67 | ₹131.93 | ₹87.58 | ₹45.42 |
Balance Sheet · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,447.01 | ₹1,040.38 | ₹911.48 | ₹818.87 |
| Current Assets | ₹1,483.13 | ₹1,139.50 | ₹921.08 | ₹760.89 |
| Total Assets | ₹2,930.14 | ₹2,179.88 | ₹1,832.56 | ₹1,579.76 |
| Current Liabilities | ₹710.20 | ₹465.69 | ₹427.68 | ₹438.96 |
| Net Current Asset | ₹772.93 | ₹673.81 | ₹493.40 | ₹321.94 |
| Non-Current Liabilities | ₹345.47 | ₹189.39 | ₹122.17 | ₹146.71 |
| Equity Capital | ₹1,874.47 | ₹1,524.81 | ₹1,282.70 | ₹994.10 |
| Total Equity & Liabilities | ₹2,930.14 | ₹2,179.88 | ₹1,832.56 | ₹1,579.76 |
Income Statement · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹2,022.99 | ₹1,476.84 | ₹1,558.58 | ₹1,191.20 |
| Other Income | ₹30.16 | ₹20.51 | ₹12.54 | ₹9.75 |
| Total Revenue | ₹2,053.15 | ₹1,497.35 | ₹1,571.12 | ₹1,200.95 |
| Total Expenses | ₹1,565.42 | ₹1,228.38 | ₹1,170.36 | ₹985.73 |
| Profit Before Tax | ₹487.73 | ₹345.37 | ₹400.77 | ₹215.21 |
| Tax | ₹124.63 | ₹85.95 | ₹101.17 | ₹52.09 |
| Profit After Tax | ₹363.11 | ₹259.43 | ₹299.60 | ₹163.12 |
| EPS - Basic | ₹283.01 | ₹202.20 | ₹233.51 | ₹127.14 |
| EPS - Diluted | ₹283.01 | ₹202.20 | ₹233.51 | ₹127.14 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹487.73 | ₹345.37 | ₹400.77 | ₹215.21 |
| Income before WC changes | ₹590.38 | ₹333.38 | ₹462.84 | ₹293.14 |
| Change in Assets | -₹359.18 | ₹28.60 | -₹98.86 | -₹153.35 |
| Change in Liabilities | ₹219.78 | ₹30.15 | ₹7.64 | ₹142.31 |
| Change in WC | -₹139.40 | ₹58.75 | -₹91.22 | -₹11.04 |
| Cash flow from Operations | ₹347.58 | ₹317.51 | ₹260.06 | ₹238.53 |
| Cash flow from Investing | -₹423.74 | -₹298.14 | -₹149.67 | -₹61.50 |
| Cash flow from Financing | ₹20.98 | ₹24.96 | -₹69.28 | -₹135.80 |
| Total Cash Flow | -₹55.18 | ₹44.33 | ₹41.11 | ₹41.24 |
| Cash (Start of the year) | ₹130.38 | ₹86.07 | ₹44.96 | ₹3.72 |
| Cash (End of the year) | ₹75.31 | ₹130.38 | ₹86.07 | ₹44.96 |
Balance Sheet · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,446.97 | ₹1,040.35 | ₹911.46 | ₹819.00 |
| Current Assets | ₹1,481.37 | ₹1,137.82 | ₹919.47 | ₹760.34 |
| Total Assets | ₹2,928.34 | ₹2,178.17 | ₹1,830.93 | ₹1,579.34 |
| Current Liabilities | ₹719.24 | ₹472.84 | ₹433.80 | ₹445.75 |
| Net Current Asset | ₹762.12 | ₹664.98 | ₹485.67 | ₹314.59 |
| Non-Current Liabilities | ₹343.24 | ₹187.54 | ₹120.59 | ₹145.22 |
| Equity Capital | ₹1,865.85 | ₹1,517.79 | ₹1,276.54 | ₹988.36 |
| Total Equity & Liabilities | ₹2,928.34 | ₹2,178.17 | ₹1,830.93 | ₹1,579.34 |
About Neuland Lab
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Neuland Lab Financial Highlights
- Revenue: Neuland Lab reported revenue of ₹2,053.16 crore in FY26 vs ₹1,497.35 crore in FY25. It showed an increase of 37.12% on a yearly basis.
- Operating Profit: Neuland Lab reported an operating profit of ₹488.98 crore in FY26 vs ₹346.33 crore in FY25. It showed an increase of 41.19% on a year-on-year basis.
- Net Profit: Neuland Lab reported a net profit of ₹364.00 crore in FY26 vs ₹260.11 crore in FY25. It showed an increase of 39.94% on a yearly basis.
Neuland Lab Quarterly Result Highlights
- Neuland Lab reported revenue of ₹788.71 crore in Mar 2026, compared with ₹447.76 crore in Dec 2025, representing an increase of 76.15% on a quarter-on-quarter (QoQ) basis.
- Neuland Lab reported an operating profit of ₹287.49 crore in Mar 2026, compared with ₹54.48 crore in Dec 2025, representing an increase of 427.70% on a quarter-on-quarter (QoQ) basis.
- Neuland Lab reported a profit of ₹212.67 crore in Mar 2026, compared with ₹40.57 crore in Dec 2025, reflecting an increase of 424.21% on a QoQ basis.
- The earnings per share (EPS) of Neuland Lab stood at ₹283.71 during Mar 2026.
Similar Stocks
FAQs on Neuland Lab Share Price
What is Neuland Lab share price today?
Neuland Lab share price is ₹18,525.00 as on 24 Jul, 2026, 15:29 IST.
How has the Neuland Lab share price performed in the past?
In the last 1 year, Neuland Lab delivered a return of 34.38%. The Neuland Lab share price hit a high of ₹20,089.00 and low of ₹11,500.00.
How much is the Mutual Fund shareholding in Neuland Lab shares?
The Mutual Fund Shareholding in Neuland Lab was 12.66% at the end of Jun 2026.
What is the the 52-week high and low of Neuland Lab shares ?
The 52-week high and low of Neuland Lab share is ₹20,089.00 and ₹11,500.00 as of 24 Jul, 2026.
What is the market cap of Neuland Lab?
The market capitalisation of Neuland Lab is ₹23,642.50 Crores as on 24 Jul, 2026.
What are the stock symbols of Neuland Lab?
The stock symbol of Neuland Lab is NEULANDLAB on the NSE, 524558 on the BSE, and the ISIN is INE794A01010.
What was yesterday's closing price of Neuland Lab shares ?
Neuland Lab shares closed yesterday at ₹18,431.00 on NSE & ₹18,427.70 on BSE
How to buy Neuland Lab shares?
To buy Neuland Lab shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Neuland Lab shares on Holidays?
No, shares of Neuland Lab or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Neuland Lab shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Neuland Lab?
The PE and PB ratio of Neuland Lab is 42.57 and 8.27 respectively, as on 24 Jul, 2026, 15:29 IST.